5 latest FDA approvals

Here are the five latest drugs or medical devices approved by the Food and Drug Administration this week.

  1. Betrixaban represents the first oral and long-lasting treatment to prevent deep vein thrombosis and pulmonary embolisms in acutely ill nonsurgical patients.

  1. The Oncomine Dx Target Test assesses tumor samples for the presence of biomarkers associated with three drug therapies approved to treat non-small cell lung cancer.

  1. Nevisense is a device intended to help clinicians detect early stages of malignant melanoma.

  1. The ClearLLab test detects several types of blood and lymphatic cancers.

  1. Illumina's next-generation sequencing kit helps clinicians identify which patients are eligible for treatment with Amgen's cancer drug Vectibix.

More articles on supply chain:

New York City faces critical blood shortage
UPS' newest delivery vehicles? Golf carts
6 drug, device recalls in June

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars